Pumpkin Seeds for Blood Sugar Regulation

Research suggests that pumpkin seeds and their extracts may support blood sugar regulation through several mechanisms, including activating insulin signaling pathways, inhibiting carbohydrate-digesting enzymes, and improving glucose uptake in cells, with the body of evidence consistently pointing in a supportive direction across a range of study models. The available evidence draws primarily from animal studies using diabetic rat and mouse models, along with laboratory cell culture experiments, a small number of studies combining pumpkin seeds with other ingredients such as flaxseed or orchid root salep, and two randomized controlled trials in humans — one in healthy adults showing roughly 35% lower postprandial blood glucose after a pumpkin seed meal, and one in hemodialysis patients showing reductions in blood glucose and insulin resistance following a mixed seed blend over 12 weeks. Studies indicate that specific compounds identified in pumpkin seeds — including flavonoids, fatty acids, tocopherols, and certain proteins — may interact with recognized targets in diabetes-related biological pathways, and some animal research suggests potential synergistic effects when pumpkin seed is combined with conventional diabetes medications. However, the preponderance of preclinical animal and cell-based evidence means these findings cannot be directly extended to human health outcomes, and the human trials conducted so far are limited in size and scope, leaving important questions about long-term effects, optimal forms of consumption, and clinical applicability still to be addressed by future research.